ProBioGen
Berlin, DE
Compare AAV CDMOs in Europe
Compare AAV CDMOs in Germany
Compare Lentiviral CDMOs in Europe
Compare Lentiviral CDMOs in Germany
Compare Biologics CDMOs in Europe
Compare Biologics CDMOs in Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: ProBioGen
- Signal Score
- 78.1/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Clean EMA record: 4 active GMP certificates (no deductions)
- Headquarters
- Berlin, DE
- Modalities
- AAV, Lentiviral, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ProBioGen
German CDMO specializing in cell line development and viral vectors.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Clean EMA record: 4 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Berlin, Germany
Modalities: AAV, Lentiviral, Biologics
Capacity assessment: 58.0/100
Sites: Berlin, Germany
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals6 articles (not scored)
1 manufacturing site: Berlin, Germany
Modalities: AAV, Lentiviral, Biologics
Capacity assessment: 58.0/100
ProBioGen EMA GMP Compliance 4 certificates
2026-08
2025-10
2025-10
2023-06
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BE_01_GMP_2026_0044 | ProBioGen AG | Germany | 2026-08-27 | COMPLIANT |
| DE_BE_01_GMP_2025_0071 | ProBioGen AG | Germany | 2025-10-01 | COMPLIANT |
| DE_BE_01_GMP_2026_0043 | ProBioGen AG | Germany | 2025-10-01 | COMPLIANT |
| DE_BE_01_GMP_2025_0045 | ProBioGen AG | Germany | 2023-06-09 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 6 articles
Company announcements, not verified evidence. They do not change any score.
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth - Manufacturing Chemist
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth Manufacturing Chemist
Simon Bulling joins ProBioGen as COO - The Pharma Letter
Simon Bulling joins ProBioGen as COO The Pharma Letter
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer - Indian Pharma Post
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion - Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion Indian Pharma Post
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer - Indian Pharma Post
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion - Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion Indian Pharma Post
Frequently Asked Questions About ProBioGen
Does ProBioGen hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for ProBioGen.
What is ProBioGen's CDMO Signal Score?
ProBioGen has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating ProBioGen for a manufacturing program?
Use the free AI matchmaker to compare ProBioGen against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Ascend Advanced Therapies
Rockville, MD · Alachua, FL · Munich, DE
Signal Score: 78.1
AAV, Lentiviral, Plasmid
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Compare ProBioGen with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.